Triptorelin to help protect fertility during cancer chemotherapy
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This Phase 3 study tests whether a hormone medicine called triptorelin (a GnRH “fertility-protecting” medicine) can better protect ovarian function while you receive chemotherapy. The goal is to help preserve fertility and reduce the risk of early ovarian failure from cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent and understand study participation
- You have certain cancers: breast cancer, acute leukemia, lymphoma, or sarcoma, confirmed by lab tests (biopsy)
- Your cancer treatment plan includes chemotherapy specific to your disease
- You have started menstrual periods before (menarche)
- Your body and organ function tests (bone marrow, kidneys, liver, and heart) are adequate and other major conditions are controlled
- Your overall health is good enough for study visits (ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a blood test (a hormone marker) can predict a child’s future risk of infertility after cancer treatment. If it works, it could help families and doctors plan earlier fertility and puberty-related care.
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
This trial tests a new hormone-blocking pill (elacestrant) with or without a shot that temporarily stops ovaries (triptorelin) for premenopausal women with early-stage, hormone-sensitive breast cancer. It aims to find a gentler treatment option before surgery.
This study tests whether taking tamoxifen and letrozole (with fertility injections) can help people with newly diagnosed, estrogen-sensitive breast cancer preserve eggs before cancer treatment starts. It may help protect future fertility by collecting eggs early, before chemotherapy or other treatments begin.
This trial tests whether adding a hormone-blocking drug (GnRH agonist) to standard chemotherapy before surgery helps premenopausal women with triple-negative breast cancer. It aims to improve treatment outcomes by targeting hormones that may fuel tumor growth.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.